A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades - Wikidata - awgldk - TriplyDB

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

http://www.wikidata.org/entity/Q27473000

about

Viral hepatitis and hepatocellular carcinoma The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis Genetic history of hepatitis C virus in East Asia Molecular evolution of hepatitis B virus over 25 years Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a Hepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111 Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence High Prevalence of Hepatitis C Virus Genotype 1b Infection in a Small Town of Argentina. Phylogenetic and Bayesian Coalescent Analysis Molecular survey of hepatitis C virus in the touristic city of Mar del Plata, Argentina The global epidemiology of hepatocellular carcinoma: present and future The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences Evolutionary analysis of hepatitis C virus gene sequences from 1953 Computational evolutionary analysis of the overlapped surface (S) and polymerase (P) region in hepatitis B virus indicates the spacer domain in P is crucial for survival A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial The mode and tempo of hepatitis C virus evolution within and among hosts.Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients.Embolization of liver tumors: Past, present and future.Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients.Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma.Embolotherapy in the management of hepatocellular carcinoma.New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0.Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men Host genetic determinants of spontaneous hepatitis C clearance.RETRACTED: Molecular epidemiology of a hepatitis C virus outbreak in a leprosy sanatorium in Japan.Terpenoids as potential chemopreventive and therapeutic agents in liver cancer Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) - the ESMERALDA trial.The population genetics and evolutionary epidemiology of RNA viruses.Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography.The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma

P2860

Q21245597-FE77E0DD-12EC-4D3D-90A9-CEF7ED6782BD Q21563395-A54E963D-4C51-4001-8932-B82B7F1072C2 Q24655361-A0A3424E-A58D-4E10-9EFE-7C171ED65081 Q24670144-8DAF34B1-6565-47FF-B85C-B76BADA25EBA Q27473217-B57A7C25-E10C-4651-BEBC-ABC92C6F0512 Q27485400-46C173AD-5A94-4C1B-9E90-8DB6BB34A7F0 Q27488844-F629571B-6267-4134-AF71-D7C5E05FE787 Q27490807-325FCC66-FA74-4F14-A4E3-3E8180991048 Q28483982-DA1AE566-36F9-415D-BBCA-408A99EF8212 Q28654353-82B06D9A-693C-449B-A9ED-D5F4D12BDDEE Q28662145-8A2FA8FD-F8C7-4B0C-AD9E-298354DF756B Q28681308-06D653F1-F9F1-41B3-AE9E-39DA15CADBBA Q30429273-DB4A5DBF-CC47-49C7-B35F-D6FBE52C303C Q33470083-C91AAA93-F05D-40AB-9C09-FB0D1F55C237 Q33818746-C6ED3B2D-9ECE-4614-AB54-52C75F7E9D0A Q33905948-E35A8A97-4134-4FAA-BB54-7E558B1FA32E Q33976481-5B61352E-D76D-435F-A14D-2BD38970EB77 Q34099104-9708AE1E-A6FC-477F-804E-D52A33A78957 Q34134940-A59136BA-A940-4B26-9377-D5C1B6D56507 Q34190390-4CF1CB81-45DE-4CFB-8C1A-242047208901 Q34302900-53BFC72C-9CF5-4D0E-BAFD-631B383395FB Q34369200-917B7121-86C1-48B1-B374-6DF3A05B2BCA Q34397639-53F47DCF-17A8-43B9-8459-157E69945B83 Q34547411-DEE9AADD-0A75-426B-8B7A-5A4C427BC7D6 Q34563655-0852E0B4-38BE-4404-91D8-DE9CF7795930 Q34605687-9B4A7789-3835-4D58-9551-AD27D239A49E Q34663297-D28446BC-92F0-4F08-92FD-50175FF9D23B Q35011376-B25E6F36-AF25-401A-B6CF-674D0A8B8223 Q35192347-AA734524-569A-4733-AD48-2776E81066FB Q35238085-B8E0AF23-CD32-46A9-8A83-87949C203587 Q35596366-0CA8104A-CF94-4BDA-9D32-9D5CDBE014B4 Q35689923-02267A41-3187-491A-A2A0-1898C79CE717 Q35697519-D7805E29-4675-4552-B566-124634241804 Q35872121-AE533892-AAC6-4FC5-8508-51645E349986 Q36082428-4AD895FF-F432-4137-9AFD-D79042A1D872 Q36112907-12A63643-E9C4-47B8-B401-9DAA4FE9FF62 Q36124126-5E2A01F2-4FEB-4577-9656-7CE0CFFB3434 Q36154934-04DFD0E2-1853-4623-8810-80C45BBF3065 Q36184218-53B266DE-EBEE-45DC-9A01-86B5C14F0C48 Q36192115-876A4C6D-C45C-4614-A4E1-4B4E6714735A

P2860

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

http://www.wikidata.org/entity/Q27473000

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

A comparison of the molecular ...... ease over the next two decades

@ast

A comparison of the molecular ...... ease over the next two decades

@en

A comparison of the molecular ...... ease over the next two decades

@nl

type

label

A comparison of the molecular ...... ease over the next two decades

@ast

A comparison of the molecular ...... ease over the next two decades

@en

A comparison of the molecular ...... ease over the next two decades

@nl

prefLabel

A comparison of the molecular ...... ease over the next two decades

@ast

A comparison of the molecular ...... ease over the next two decades

@en

A comparison of the molecular ...... ease over the next two decades

@nl

P1433

Q27473000-4DABD6D0-B8DA-4018-BB75-2CFA11F31201

P1476

Q27473000-0A160D9E-0506-4898-8CC5-D7F36A8B8F3C

P2093

Q27473000-457C740F-A1AA-4C3A-AB06-74924C0C929C

Q27473000-50759B70-5C69-4DA1-86D3-A80BCF71C22B

Q27473000-6AC99A16-413D-4449-86D7-228B25C6FF01

Q27473000-9E373DEB-CA73-496B-8AE0-0A80A532414B

Q27473000-C4077E45-6409-4201-8A8F-5E4C9C174187

Q27473000-DAC539CA-B093-4805-BF5B-18451D3DA7AE

P2860

Q27473000-37020C22-A85D-46B5-A1C4-AEC878E18882

Q27473000-3AB5466E-0E57-49F5-BEFA-E60940D3005B

Q27473000-3D4E6A4B-1A6B-4316-B0BE-7653AEF21CB9

Q27473000-4BBBFCA5-ED1E-483E-BABD-232FF3C502EA

Q27473000-5B89D586-4F48-485F-BC6A-B45D85F1A8BA

Q27473000-664B10E9-A065-461A-B615-631CBA2C218B

Q27473000-6B5500CB-45D0-4D56-9D6E-268DFE821E3E

Q27473000-6C052FD8-B737-456B-B3DD-74C3E7E0BBE4

Q27473000-72DC18F5-5AEB-452E-B23A-9F95E482F941

Q27473000-73B057AD-4954-4B39-9545-B8726630320D

P304

Q27473000-ABE25DB3-DE14-414D-B42A-BA69E70CC15F

P31

Q27473000-5A377714-F06B-4931-A973-BC6FEA8EFF75

P3181

Q27473000-8CD010FA-9BAC-4013-90DD-AACEA2C66947

P356

Q27473000-3092BDB9-A3F6-4671-A684-C0AFD53706F2

P407

Q27473000-4247EFDB-52D9-423B-9B1F-DAD0FAB4FE9E

P433

Q27473000-D003B76A-03FE-4095-AF05-1B0BFF179B5C

P478

Q27473000-65EA4233-7C8D-48F1-BE3F-2C4EFB682A05

P50

Q27473000-9902A0E0-0814-4DC7-956E-15B106C19D49

P577

Q27473000-FD33D833-2E33-4E37-9E52-CC47B5B440B1

P5875

Q27473000-ACDC7BB3-FF99-4885-86AA-EDE60B2B0CCE

P698

Q27473000-C5537319-5EE6-4E80-959C-4B84F34E88C1

P921

Q27473000-CDDE6067-16D5-4686-AAB1-1E5C99042B22

P932

Q27473000-BE7772B0-931F-4AB1-8403-8DBB15375E1D

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A comparison of the molecular ...... ease over the next two decades

@en

P2093

Anthony E T Yeo

http://www.w3.org/2001/XMLSchema#string

Harvey J Alter

http://www.w3.org/2001/XMLSchema#string

J Wai-Kuo Shih

http://www.w3.org/2001/XMLSchema#string

Kousuke Hanada

http://www.w3.org/2001/XMLSchema#string

Masashi Mizokami

http://www.w3.org/2001/XMLSchema#string

Yasuhito Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic organization and diversity of the hepatitis C virus

PAML: a program package for phylogenetic analysis by maximum likelihood

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

Positive Darwinian evolution in human influenza A viruses

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

Rapid evolution of RNA genomes

MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

P304

15584-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2574812

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.242608099

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Takashi Gojobori

P577

2002-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11028866

http://www.w3.org/2001/XMLSchema#string

P698

12438687

http://www.w3.org/2001/XMLSchema#string

P921

P932

137760

http://www.w3.org/2001/XMLSchema#string